(Q37803578)

English

Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders

scientific article published on January 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 August 2017

Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders (English)

1 reference

Europe PubMed Central

23 August 2017

attention deficit hyperactivity disorder

0 references

pharmacotherapy

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Robert L Findling

2

object named as

Robert L Findling

1 reference

Europe PubMed Central

23 August 2017

author name string

Brieana M Rowles

1

1 reference

Europe PubMed Central

23 August 2017

publication date

1 January 2010

1 reference

Europe PubMed Central

23 August 2017

Developmental Disabilities Research Reviews

1 reference

Europe PubMed Central

23 August 2017

16

1 reference

Europe PubMed Central

23 August 2017

3

1 reference

Europe PubMed Central

23 August 2017

273-282

1 reference

Europe PubMed Central

23 August 2017

Guanfacine extended release in the treatment of attention deficit hyperactivity disorder in children and adolescents

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

21 January 2018

Double-blind, placebo-controlled trial of clonidine in hyperactive children with mental retardation

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Fenfluramine and methylphenidate in children with mental retardation and ADHD: clinical and side effects.

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical effects of methylphenidate and thioridazine in intellectually subaverage children.

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial.

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of children with Williams syndrome with methylphenidate.

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychopharmacology in fragile X syndrome--present and future

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurobehavioral disorders in children, adolescents, and young adults with Down syndrome

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Risperidone use in children with Down syndrome, severe intellectual disability, and comorbid autistic spectrum disorders: a naturalistic study

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of risperidone and methylphenidate for reducing ADHD symptoms in children and adolescents with moderate mental retardation

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberous sclerosis complex: a review of neurological aspects

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Medication effects on symptoms of attention-deficit/hyperactivity disorder in children with fetal alcohol spectrum disorder

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Donepezil in the treatment of ADHD-like symptoms in youths with pervasive developmental disorder: a case series

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Ziprasidone for maladaptive behavior and attention-deficit/hyperactivity disorder symptoms in autistic disorder.

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychiatric and behavioral disorders in persons with Down syndrome

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement in behaviour and attention in an autistic patient treated with ziprasidone

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of stimulant medication in children with the fragile X syndrome

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects and noneffects of methylphenidate in children with mental retardation and ADHD

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD.

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Guanfacine in children with autism and/or intellectual disabilities

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Clonidine treatment of hyperactive and impulsive children with autistic disorder

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Attention-deficit disorders and epilepsy in childhood: incidence, causative relations and treatment possibilities

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

The association of neurofibromatosis type 1 and attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Review of Pediatric Attention Deficit/Hyperactivity Disorder for the General Psychiatrist

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological Treatment Options for Autism Spectrum Disorders in Children and Adolescents

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of psychiatric disorders in 4 to 16-year-olds with Williams syndrome

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of ADHD in neurofibromatosis type 1.

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychiatric Disorders in Persons with Down Syndrome

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of methylphenidate in Native American children with fetal alcohol syndrome and attention deficit/hyperactivity disorder: a controlled pilot study

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of ADDH in mentally retarded children: a preliminary study

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD.

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders.

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Brief report: response to methylphenidate in two children with Williams syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of methylphenidate in the treatment of children with autistic disorder.

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective open trial of guanfacine in children with pervasive developmental disorders.

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Atomoxetine for attention-deficit/hyperactivity disorder symptoms in children with pervasive developmental disorders: a pilot study.

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and tolerability of methylphenidate in preschool children with ADHD.

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical necessity for assessing Attention Deficit/Hyperactivity Disorder (AD/HD) symptoms in children with high-functioning Pervasive Developmental Disorder (PDD).

1 reference

https://api.crossref.org/works/10.1002%2FDDRR.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DDRR.120

1 reference

Europe PubMed Central

23 August 2017

1 reference

Europe PubMed Central

23 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37803578&oldid=1728639687"